FARO Reports Sales Growth of 25.7% in 2007; Orders Increase 21.8% for 2007

LAKE MARY, Fla., Feb. 13 /PRNewswire-FirstCall/ -- FARO Technologies, Inc.
(Nasdaq: FARO) today announced results for the fourth quarter ended December
31, 2007. Net income for the fourth quarter was $8.4 million, or $0.50 per
diluted share, an increase of $4.7 million, compared to $3.7 million, or $0.25
per diluted share, in the fourth quarter of 2006. Net income for fiscal 2007
was $18.1 million, or $1.15 per diluted share, compared to $8.2 million, or
$0.56 per diluted share for fiscal 2006. Fiscal 2007 results include a charge
of $2.65 million, or $0.21 per diluted share, for the estimated fines and
penalties that the Company anticipates could be necessary to resolve the
previously announced Foreign Corrupt Practices Act ("FCPA") matter with the
U.S. Department of Justice ("DOJ") and U.S. Securities and Exchange Commission
("SEC").(1)
Sales for the fourth quarter of 2007 were $59.2 million, an increase of
$15.3 million, or 34.9%, from $43.9 million in the fourth quarter of 2006.
New order bookings for the fourth quarter of 2007 were $65.4 million, an
increase of $15.6 million, or 31.3%, compared to $49.8 million in the year-ago
quarter. Fiscal 2007 sales were $191.6 million, an increase of 25.7% compared
to fiscal 2006 sales of $152.4 million, slightly above the Company's full-year
guidance of 20-25% sales growth. New order bookings for fiscal 2007 were
$197.8 million, a 21.8% increase from $162.4 million in fiscal 2006.
"Once again, the FARO team around the world demonstrated its ability to
perform," stated Jay Freeland, FARO's President and CEO. "Sales growth for
2007 was above the target range of 20-25% that we have been communicating all
year. As always, fourth quarter sales were particularly strong with all three
regions growing more than 20%."
Gross margin for the fourth quarter of 2007 was 60.0%, compared to 58.8%
in the fourth quarter of 2006. Gross margin increased primarily as the result
of an increase in unit sales in product lines with lower unit costs due to
continuing productivity improvements. The gross margin for fiscal 2007 was
60.0% compared to 58.7% in fiscal 2006 and within the Company's previously
issued guidance of 58% to 60%.
Selling expenses as a percentage of sales decreased to 27.3% in the fourth
quarter of 2007 compared to 29.2% in the fourth quarter of 2006. Selling
expenses as a percentage of sales for fiscal 2007 were 29.3% compared to 29.7%
for fiscal 2006.
General and administrative expenses were 11.8% of sales for the fourth
quarter of 2007 compared to 14.2% of sales in the fourth quarter of 2006.
General and administrative expenses in the fourth quarter of 2006 included
$1.5 million of professional fees related to the Company's Foreign Corrupt
Practices Act ("FCPA") matter and its patent litigation. General and
administrative expenses were 13.3% of sales in 2007 and included the accrual
of $2.65 million for the estimated fines and penalties that could be necessary
to resolve the FCPA matter and $1.1 million of professional fees related to
the Company's FCPA matter and resolution of the patent litigation. General
and administrative expenses were 16.1% of sales in fiscal 2006 and included
$6.8 million of professional fees related to the FCPA matter and patent
litigation.
Research and development ("R&D") expenses were $3.1 million for the fourth
quarter of 2007, up from $1.8 million in the fourth quarter of 2006. R&D
expenses for fiscal 2007 were $10.3 million, or 5.4% of sales, an increase of
$3.1 million from $7.2 million in fiscal 2006, or 4.7% of sales. The increase
was driven primarily by costs associated with the recent launches of the new
Quantum FAROArm and Fusion FAROArm product lines.
Operating margin for the fourth quarter of 2007 was 13.8%, compared to
8.8% in the year ago quarter.
Income tax expense was $1.1 million for the fourth quarter of 2007
compared to $0.8 million in the fourth quarter of 2006. The Company's
effective tax rate for 2007 increased to 21.5% compared to 16.2% for fiscal
2006 primarily as a result of the increase in non-deductible expenses for U.S.
income tax purposes associated with the FCPA matter. The Company's effective
income tax rate, excluding the effects of the $2.65 million charge for the
estimated fines and penalties associated with the FCPA matter, would have been
17.0%.(2)
Full Year 2008 Sales and Gross Margin Guidance
"2007 was a tremendous year for FARO combining significant growth with
great productivity, several new products and fantastic execution. Although
there is clearly increased economic pressure globally, particularly in the
U.S., we continue to see strong demand for our products. As such, in 2008 we
are maintaining our guidance ranges of approximately 20% - 25% top line growth
and gross margin of 58% to 60%," Freeland concluded.

(1) The Company believes that measuring net income and net income per
diluted share without the impact of the $2.65 million FCPA charge and
the $0.6 million of related tax effects is useful to management and
investors (when presented in conjunction with the comparable GAAP
measure of net income and net income per diluted share) because the
impact of the $2.65 million charge on the Company's tax rate could
otherwise be unclear to investors. In addition, management refers to
these financial measures to facilitate internal and external
comparisons to the Company's historical operating results.

(2) The Company believes that calculating its effective tax rate without
the impact of the FCPA charge is useful to management and investors
because the impact of the $2.65 million charge on the Company's tax
rate could otherwise be unclear to investors. In addition, management
refers to the adjusted effective tax rate to facilitate internal and
external comparisons to the Company's historical tax rate. The
Company's 2007 effective tax rate without the impact of the FCPA
charge would have been calculated in accordance with FIN No. 18.

This press release contains forward-looking statements (within the meaning
of the Private Securities Litigation Reform Act of 1995) that are subject to
risks and uncertainties, such as statements about our plans, objectives,
projections, expectations, assumptions, strategies, or future events.
Statements that are not historical facts or that describe the Company's plans,
objectives, projections, expectations, assumptions, strategies, or goals are
forward-looking statements. In addition, words such as "may," "believes,"
"anticipates," "expects," "intends," "plans," "seeks," "estimates," "will,"
"should," "could," "projects," "forecast," "target," "goal," and similar
expressions or discussions of our strategy or other intentions identify
forward-looking statements. Other written or oral statements, which constitute
forward-looking statements, also may be made by the Company from time to time.
Forward-looking statements are not guarantees of future performance and are
subject to various known and unknown risks, uncertainties, and other factors
that may cause actual results, performances, or achievements to differ
materially from future results, performances, or achievements expressed or
implied by such forward-looking statements. Consequently, undue reliance
should not be placed on these forward-looking statements.
Factors that could cause actual results to differ materially from what is
expressed or forecasted in forward-looking statements include, but are not
limited to:
-- our inability to further penetrate our customer base;
-- development by others of new or improved products, processes or
technologies that make our products obsolete or less competitive;
-- our inability to maintain our technological advantage by developing
new products and enhancing our existing products;
-- our inability to successfully identify and acquire target companies or
achieve expected benefits from acquisitions that are consummated;
-- the cyclical nature of the industries of our customers and the
financial condition of our customers;
-- the fact that the market potential for the CAM2 market and the
potential adoption rate for our products are difficult to quantify and
predict;
-- the inability to protect our patents and other proprietary rights in
the United States and foreign countries;
-- fluctuations in our annual and quarterly operating results, and the
inability to achieve our financial operating targets as a result of a
number of factors including, but not limited to (i) litigation and
regulatory actions brought against us, (ii) quality issues with our
products, (iii) excess or obsolete inventory,(iv) raw material price
fluctuations, (v) expansion of our manufacturing capability and other
inflationary pressures, (vi) the size and timing of customer orders,
(vii) the amount of time that it takes to fulfill orders and ship our
products, (viii) the length of our sales cycle to new customers and
the time and expense incurred in further penetrating our existing
customer base, (ix) increases in operating expenses required for
product development and new product marketing, (x) costs associated
with new product introductions, such as product development,
marketing, assembly line start-up costs and low introductory period
production volumes, (xi) the timing and market acceptance of new
products and product enhancements, (xii) customer order deferrals in
anticipation of new products and product enhancements, (xiii) our
success in expanding our sales and marketing programs, (xiv) costs
associated with opening new sales offices outside of the United
States, (xv) fluctuations in revenue without proportionate adjustments
in fixed costs, (xvi) the efficiencies achieved in managing
inventories and fixed assets; (xvii) investments in potential
acquisitions or strategic sales, product or other initiatives,
(xviii) shrinkage or other inventory losses due to product
obsolescence, scrap, or material price changes, (xix) adverse changes
in the manufacturing industry and general economic conditions, (xx)
compliance with government regulations, including health, safety, and
environmental matters, and (xxi) other factors noted herein;
-- changes in gross margins due to changing product mix of products sold
and the different gross margins on different products,
-- our inability to successfully implement the requirements of
Restriction of use of Hazardous Substances (RoHS) and Waste Electrical
and Electronic Equipment (WEEE) compliance into our products;
-- the inability of our products to displace traditional measurement
devices and attain broad market acceptance;
-- the impact of competitive products and pricing in the CAM2 market and
the broader market for measurement and inspection devices;
-- the effects of increased competition as a result of recent
consolidation in the CAM2 market;
-- risks associated with expanding international operations, such as
fluctuations in currency exchange rates, difficulties in staffing and
managing foreign operations, political and economic instability,
compliance with import and export regulations, and the burdens of
complying with a wide variety of foreign laws and labor practices;
-- unforeseen developments in our FCPA matter or in complying with the
FCPA in the future;
-- the fact that there is no assurance that the Company's discussions
with the SEC and the DOJ will result in a resolution of the FCPA
matter with either the DOJ or the SEC or that any such resolution, if
reached, may differ from the resolution currently anticipated by the
Company;
-- the fact that predicting when the FCPA matter will be finally resolved
with the SEC and the DOJ is not possible;
-- the fact that the amount of monetary sanctions ultimately paid by the
Company to the SEC and the DOJ in resolving the FCPA matter, whether
imposed on the Company or agreed to by settlement, may exceed the
amount that that has been reserved by the Company;
-- the outcome of the class action securities litigation;
-- higher than expected increases in expenses relating to our Asia
Pacific expansion or our Singapore manufacturing facility;
-- our inability to find less expensive alternatives to stock options to
attract and retain employees;
-- the loss of our Chief Executive Officer, our Chief Technology Officer,
our Chief Financial Officer, or other key personnel;
-- difficulties in recruiting research and development engineers, and
application engineers;
-- the failure to effectively manage our growth;
-- variations in the effective tax rate and the difficulty predicting the
tax rate on a quarterly and annual basis;
-- the loss of key suppliers and the inability to find sufficient
alternative suppliers in a reasonable period or on commercially
reasonable terms; and
-- the other risks detailed in the Company's Annual Report on Form 10-K
and other filings from time to time with the Securities and Exchange
Commission.

Forward-looking statements in this release represent the Company's
judgment as of the date of this release. The Company undertakes no obligation
to update publicly any forward-looking statements, whether as a result of new
information, future events, or otherwise.
About FARO
With approximately 16,000 installations and 7,400 customers globally, FARO
Technologies, Inc. designs, develops, and markets portable, computerized
measurement devices and software used to create digital models -- or to
perform evaluations against an existing model -- for anything requiring highly
detailed 3-D measurements, including part and assembly inspection, factory
planning and asset documentation, as well as specialized applications ranging
from surveying, recreating accident sites and crime scenes to digitally
preserving historical sites.
FARO's technology increases productivity by dramatically reducing the
amount of on-site measuring time, and the various industry-specific software
packages enable users to process and present their results quickly and more
effectively.
Principal products include the world's best-selling portable measurement
arm -- the FaroArm; the world's best-selling laser tracker -- the FARO Laser
Tracker X and Xi; the FARO Laser ScanArm; FARO Laser Scanner LS; the FARO
Gage, Gage-PLUS and PowerGAGE; and the CAM2 family of advanced CAD-based
measurement and reporting software. FARO Technologies is ISO-9001 certified
and ISO-17025 laboratory registered.

FARO TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(UNAUDITED)

Three Months Ended Year Ended

(in thousands, except
share and per share data) Dec 31, Dec 31, Dec 31, Dec 31,
2007 2006 2007 2006

SALES $59,228 $43,942 $191,617 $152,405
COST OF SALES (exclusive
of depreciation and
amortization, shown
separately below) 23,700 18,125 76,574 62,947
GROSS PROFIT 35,528 25,817 115,043 89,458

OPERATING EXPENSES:
Selling 16,183 12,824 56,134 45,282
General and administrative 7,012 6,258 25,508 24,554
Depreciation and
amortization 1,021 1,039 4,034 4,135
Research and development 3,127 1,838 10,256 7,228

Total operating expenses 27,343 21,959 95,932 81,199

INCOME FROM OPERATIONS 8,185 3,858 19,111 8,259

OTHER (INCOME) EXPENSE
Interest income (854) (227) (2,036) (743)
Other (income) expense, net (471) (351) (1,898) (790)
Interest expense 2 8 9 16

INCOME BEFORE INCOME TAX 9,508 4,428 23,036 9,776

INCOME TAX EXPENSE 1,104 770 4,943 1,580

NET INCOME $8,404 $3,658 $18,093 $8,196

NET INCOME PER SHARE - BASIC $0.51 $0.25 $1.17 $0.57

NET INCOME PER SHARE -
DILUTED $0.50 $0.25 $1.15 $0.56

Weighted average shares -
Basic 16,584,477 14,426,478 15,443,259 14,397,050

Weighted average shares -
Diluted 16,777,426 14,610,555 15,722,215 14,560,331

FARO TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
December 31, December 31,
(in thousands, except share data) 2007 2006

ASSETS
Current Assets:
Cash and cash equivalents $25,798 $15,689
Short-term investments 77,375 15,790
Accounts receivable, net 54,767 42,706
Inventories 29,100 23,429
Deferred income taxes, net 2,841 1,845
Prepaid expenses and other current assets 6,719 3,222
Total current assets 196,600 102,681
Property and Equipment:
Machinery and equipment 12,895 9,131
Furniture and fixtures 5,008 3,988
Leasehold improvements 3,296 2,615
Property and equipment at cost 21,199 15,734
Less: accumulated depreciation and
amortization (13,672) (8,889)
Property and equipment, net 7,527 6,845
Goodwill 19,117 17,266
Intangible assets, net 5,970 6,221
Service Inventory 10,865 7,278
Deferred income taxes, net 3,460 3,985

Total Assets $243,539 $144,276

LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
Accounts payable $12,450 $11,182
Accrued liabilities 17,989 10,379
Income taxes payable 2,266 2,151
Current portion of unearned service
revenues 8,594 4,569
Customer deposits 337 618
Current portion of long-term debt and
obligations under capital leases 18 90
Total current liabilities 41,654 28,989
Unearned service revenues - less
current portion 6,091 2,917
Deferred tax liability, net 1,073 1,200
Long-term debt and obligations under
capital leases - less current portion 222 115
Total Liabilities 49,040 33,221

Commitments and contingencies

Shareholders' Equity:

Common stock - par value $.001,
50,000,000 shares authorized;
16,700,966 and 14,586,402 issued;
16,644,052 and 14,464,715
outstanding, respectively 17 14
Additional paid-in-capital 146,489 85,160
Retained earnings 43,546 25,452
Accumulated other comprehensive income (loss) 4,598 580
Common stock in treasury, at cost -
40,000 shares (151) (151)
Total Shareholders' Equity 194,499 111,055
Total Liabilities and Shareholders' Equity $243,539 $144,276

FARO TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
Year Ended December 31,
(in thousands) 2007 2006
CASH FLOWS FROM:
OPERATING ACTIVITIES:
Net income $18,093 $8,196
Adjustments to reconcile net income
to net cash provided by (used in)
operating activities:
Depreciation and amortization 4,034 4,135
Amortization of stock options and
restricted stock units 1,216 401
Provision for bad debts 373 230
Deferred income tax (benefit) expense (464) 20
Change in operating assets and liabilities:
Decrease (increase) in:
Accounts receivable (9,121) (12,173)
Inventories (7,265) 2,804
Prepaid expenses and other current assets (3,208) (933)
Income tax (benefit) expense from
exercise of stock options (963) (102)
Increase (decrease) in:
Accounts payable and accrued liabilities 9,884 3,062
Income taxes payable 1,278 526
Customer deposits (269) 399
Unearned service revenues 8,007 3,189
Net cash provided by (used in)
operating activities 21,595 9,754

INVESTING ACTIVITIES:
Acquisition of iQVolution
Purchases of property and equipment (2,930) (3,357)
Payments for intangible assets (359) (820)
(Purchases of) proceeds from short-
term investments (61,585) 700
Net cash used in investing activities (64,874) (3,477)

FINANCING ACTIVITIES:
Payments of capital leases (92) (204)
Income tax benefit (expense) from
exercise of stock options 963 102
Proceeds from issuance of stock, net 58,421 361
Net cash provided by financing activities 59,292 259

EFFECT OF EXCHANGE RATE CHANGES ON
CASH AND CASH EQUIVALENTS (5,904) (125)

INCREASE (DECREASE) IN CASH AND CASH
EQUIVALENTS 10,109 6,411

CASH AND CASH EQUIVALENTS, BEGINNING
OF PERIOD 15,689 9,278

CASH AND CASH EQUIVALENTS, END OF PERIOD $25,798 $15,689

SOURCE FARO Technologies, Inc.

Keith Bair, Senior Vice President and CFO, of FARO Technologies, Inc.,
+1-407-333-9911, keith.bair@FARO.com